Molecule intelOpportunity: Moderate0

Colistimethate Sodium 3miu

9 brands · 7 companies · product forms

Opportunity snapshot

Launch attractiveness
40
Market saturation
18
Price room
100
Regulatory risk
0
9
brands
7
companies
Rs 3,000.68
median price
17
price points
24.01x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 22%

Price room

Across observed sources and strengths
CheapestRs 1,199.81
MedianRs 3,000.68
Most expensiveRs 28,806.97
Spread24.01×
Sources: DRAP-official, Servaid

max/min price ratio 24.01x across 17 trusted points (Rs 1199.81-28806.97). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 5 live products for Colistimethate Sodium 3miu — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 9 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 24.01x across 17 trusted points (Rs 1199.81-28806.97). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.